1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Seizures Global Clinical Trials Review, H2, 2014

Seizures Global Clinical Trials Review, H2, 2014

  • July 2014
  • -
  • GlobalData
  • -
  • 112 pages

Seizures Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Seizures Global Clinical Trials Review, H2, 2014" provides data on the Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Seizures Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Seizures 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Seizures to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Seizures to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Seizures 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Seizures Therapeutics Clinical Trials 33
Prominent Drugs 34
Latest Clinical Trials News on Seizures 35
Jun 17, 2014: Qudexy XR (Topiramate) Extended-Release Capsules Phase 3 Data Published In Epilepsia 35
Jun 16, 2014: Eisai Announces Phase III Trial with Antiepileptic Drug Perampanel Meets Primary Endpoint as Adjunctive Therapy in Patients with Uncontrolled Primary Generalized Tonic-Clonic Seizures 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
UCB S.A. 36
Clinical Trial Overview of UCB S.A. 36
Pfizer Inc. 42
Clinical Trial Overview of Pfizer Inc. 42
Eisai Co., Ltd. 46
Clinical Trial Overview of Eisai Co., Ltd. 46
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Johnson and Johnson 52
Clinical Trial Overview of Johnson and Johnson 52
GlaxoSmithKline plc 54
Clinical Trial Overview of GlaxoSmithKline plc 54
Bial - Portela and Ca, S.A. 56
Clinical Trial Overview of Bial - Portela and Ca, S.A. 56
SK Holdings Co., Ltd. 57
Clinical Trial Overview of SK Holdings Co., Ltd. 57
H. Lundbeck A/S 58
Clinical Trial Overview of H. Lundbeck A/S 58
Boehringer Ingelheim Auslandsbeteiligungs GmbH 59
Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH 59
Clinical Trial Overview of Top Institutes / Government 60
National Institute of Neurological Disorders and Stroke 60
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 60
Assistance Publique - Hopitaux de Paris 61
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 61
All India Institute of Medical Sciences 62
Clinical Trial Overview of All India Institute of Medical Sciences 62
Cincinnati Children's Hospital Medical Center 63
Clinical Trial Overview of Cincinnati Children's Hospital Medical Center 63
University of California, San Diego 64
Clinical Trial Overview of University of California, San Diego 64
Emory University 65
Clinical Trial Overview of Emory University 65
Yonsei University 66
Clinical Trial Overview of Yonsei University 66
Medical University of South Carolina 67
Clinical Trial Overview of Medical University of South Carolina 67
Eunice Kennedy Shriver National Institute of Child Health and Human Development 68
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 68
Shiraz University of Medical Sciences 69
Clinical Trial Overview of Shiraz University of Medical Sciences 69
Five Key Clinical Profiles 70
Appendix 110
Abbreviations 110
Definitions 110
Research Methodology 111
Secondary Research 111
About GlobalData 112
Contact Us 112
Disclaimer 112
Source 112

List of Tables
Seizures Therapeutics, Global, Clinical Trials by Region, 2014* 7
Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Seizures Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Seizures Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Seizures Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Seizures Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Seizures Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Seizures Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Seizures Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 30
Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 31
Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 32
Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014* 36
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 42
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 46
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 49
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 52
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 54
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Bial - Portela and Ca, S.A., 2014* 56
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by SK Holdings Co., Ltd., 2014* 57
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2014* 58
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Auslandsbeteiligungs GmbH, 2014* 59
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 60
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 61
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014* 62
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2014* 63
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014* 64
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 65
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 66
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2014* 67
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 68
Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014* 69

List of Figures
Seizures Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Seizures Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Seizures Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Seizures Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Seizures Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Seizures Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 30
Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 31
Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 32
Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
GlobalData Methodology 111

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Global Clinical Trial Management System Growth, Trends and Forecasts (2017 - 2022)

Global Clinical Trial Management System Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The Global market for Clinical Trial Management System is expected to reach $2 billion by the end of 2020 growing at a CAGR of around 12.5% from 2014 to 2021. Clinical Trial Management System is a system ...

Global Clinical Trials Market Growth, Trends and Forecasts (2017 - 2022)

Global Clinical Trials Market Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.